McKesson Corporation

NYSE:MCK Voorraadrapport

Marktkapitalisatie: US$62.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

McKesson Beheer

Beheer criteriumcontroles 3/4

De CEO McKesson's is Brian Tyler, benoemd in Apr2019, heeft een ambtstermijn van 5.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 19.00M, bestaande uit 7.8% salaris en 92.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.061% van de aandelen van het bedrijf, ter waarde $ 38.96M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.5 jaar en 3.1 jaar.

Belangrijke informatie

Brian Tyler

Algemeen directeur

US$19.0m

Totale compensatie

Percentage CEO-salaris7.8%
Dienstverband CEO5.5yrs
Eigendom CEO0.06%
Management gemiddelde ambtstermijn3.5yrs
Gemiddelde ambtstermijn bestuur3.1yrs

Recente managementupdates

Recent updates

McKesson: The Correction Is Not Over

Sep 10

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

Aug 22
McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

Jul 04

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

May 09
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Mar 14
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

Jan 29
Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

Jan 19

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

Nov 20
If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

Oct 30
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson: Still Trading For A Huge Discount

Sep 06

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Aug 21
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

Jul 27
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

May 23
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Apr 17
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Feb 22
Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

Feb 08

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12
McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

Sep 19
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

McKesson to acquire Rx Savings Solutions in $875M deal

Sep 19

Analyse CEO-vergoeding

Hoe is Brian Tyler's beloning veranderd ten opzichte van McKesson's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

US$3b

Mar 31 2024US$19mUS$1m

US$3b

Dec 31 2023n/an/a

US$3b

Sep 30 2023n/an/a

US$3b

Jun 30 2023n/an/a

US$4b

Mar 31 2023US$20mUS$1m

US$4b

Dec 31 2022n/an/a

US$3b

Sep 30 2022n/an/a

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022US$18mUS$1m

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021n/an/a

-US$5b

Jun 30 2021n/an/a

-US$4b

Mar 31 2021US$15mUS$1m

-US$5b

Dec 31 2020n/an/a

-US$4b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$922m

Mar 31 2020US$15mUS$1m

US$906m

Dec 31 2019n/an/a

-US$905m

Sep 30 2019n/an/a

-US$626m

Jun 30 2019n/an/a

US$601m

Mar 31 2019US$13mUS$929k

US$33m

Compensatie versus markt: De totale vergoeding ($USD 19.00M ) Brian } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).

Compensatie versus inkomsten: De vergoeding van Brian is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Brian Tyler (57 yo)

5.5yrs

Tenure

US$18,997,543

Compensatie

Mr. Brian S. Tyler, Ph D., has been an Independent Director at Republic Services, Inc. since April 1, 2021. He served as Chairman of Supervisory Board at McKesson Europe AG since August 9, 2018 until 2022....


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Brian Tyler
CEO & Director5.5yrsUS$19.00m0.061%
$ 38.3m
Britt Vitalone
Executive VP & CFO6.8yrsUS$6.78m0.011%
$ 7.1m
Michele Lau
Executive VP & Chief Legal Officerless than a yearUS$8.81m0.00011%
$ 69.2k
LeAnn Smith
Executive VP & Chief Human Resources Officer1.8yrsUS$3.54m0.0016%
$ 982.0k
Thomas Rodgers
Executive VP and Chief Strategy & Business Development Officer4.3yrsUS$3.18m0.0020%
$ 1.2m
Napoleon Rutledge
Senior VP2.6yrsgeen gegevens0.0015%
$ 956.8k
Francisco Fraga
Executive VPless than a yeargeen gegevensgeen gegevens
Rachel Rodriguez
Vice President of Investor Relationsno datageen gegevensgeen gegevens
Pete Slone
Senior Vice President of Corporate Public Affairs9.3yrsgeen gegevensgeen gegevens
Kirk Kaminsky
President of The US Pharmaceutical & Specialty Solutions Business5.5yrsgeen gegevensgeen gegevens
Paul Smith
Senior Vice President of Taxesno datageen gegevensgeen gegevens
Kevin Emerson
Senior Vice President of Finance Operations2.6yrsgeen gegevensgeen gegevens

3.5yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MCK wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Brian Tyler
CEO & Director5.5yrsUS$19.00m0.061%
$ 38.3m
Donald Knauss
Independent Chairman of the Board10yrsUS$555.22k0.0016%
$ 1.0m
Maria Martinez
Independent Director5yrsUS$335.08k0.00027%
$ 170.0k
Dominic Caruso
Independent Director6.1yrsUS$336.21k0.00027%
$ 170.0k
Deborah Dunsire
Directorless than a yeargeen gegevensgeen gegevens
James Hinton
Independent Director2.8yrsUS$315.08k0%
$ 0
Webster Dunbar
Independent Director2.5yrsUS$315.08k0%
$ 0
Kathleen Wilson-Thompson
Independent Director2.8yrsUS$315.08k0%
$ 0
Richard Carmona
Independent Director3.1yrsUS$313.71k0%
$ 0
Kevin Ozan
Independent Directorless than a yearUS$139.34k0.000010%
$ 6.3k
Bradley Lerman
Independent Director6.5yrsUS$328.71k0%
$ 0

3.1yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MCK wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).